Yuhan Corp. (KO:000100) — Market Cap & Net Worth
Market Cap & Net Worth: Yuhan Corp. (000100)
Yuhan Corp. (KO:000100) has a market capitalization of $3.67 Billion (₩5.41 Trillion) as of August 3, 2026. Listed on the KO stock exchange, this Korea-based company holds position #4279 globally and #92 in its home market, demonstrating a 2.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuhan Corp.'s stock price ₩73500.00 by its total outstanding shares 73615781 (73.62 Million). See reinvestment intensity of Yuhan Corp. to understand how much of operating cash flow is reinvested back into capital assets.
Yuhan Corp. Market Cap History: 2015 to 2026
Yuhan Corp.'s market capitalization history from 2015 to 2026. Data shows growth from $1.74 Billion to $3.67 Billion (7.65% CAGR).
Yuhan Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuhan Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Yuhan Corp.'s market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.03x
Yuhan Corp.'s market cap is 0.03 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.35 Billion | $1.32 Trillion | $161.25 Billion | 0.00x | 0.01x |
| 2017 | $1.57 Billion | $1.46 Trillion | $109.03 Billion | 0.00x | 0.01x |
| 2018 | $1.55 Billion | $1.52 Trillion | $57.48 Billion | 0.00x | 0.03x |
| 2019 | $1.90 Billion | $1.48 Trillion | $40.01 Billion | 0.00x | 0.05x |
| 2020 | $3.19 Billion | $1.62 Trillion | $192.76 Billion | 0.00x | 0.02x |
| 2021 | $2.79 Billion | $1.69 Trillion | $102.58 Billion | 0.00x | 0.03x |
| 2022 | $2.72 Billion | $1.78 Trillion | $95.14 Billion | 0.00x | 0.03x |
| 2023 | $3.43 Billion | $1.86 Trillion | $136.20 Billion | 0.00x | 0.03x |
| 2024 | $5.96 Billion | $2.07 Trillion | $70.69 Billion | 0.00x | 0.08x |
| 2025 | $5.61 Billion | $2.19 Trillion | $194.08 Billion | 0.00x | 0.03x |
Competitor Companies of 000100 by Market Capitalization
Companies near Yuhan Corp. in the global market cap rankings as of August 3, 2026.
Key companies related to Yuhan Corp. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
Yuhan Corp. Historical Marketcap From 2015 to 2026
Between 2015 and today, Yuhan Corp.'s market cap moved from $1.74 Billion to $ 3.67 Billion, with a yearly change of 7.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩3.67 Billion | -34.61% |
| 2025 | ₩5.61 Billion | -5.94% |
| 2024 | ₩5.96 Billion | +73.69% |
| 2023 | ₩3.43 Billion | +26.29% |
| 2022 | ₩2.72 Billion | -2.57% |
| 2021 | ₩2.79 Billion | -12.60% |
| 2020 | ₩3.19 Billion | +67.63% |
| 2019 | ₩1.90 Billion | +22.53% |
| 2018 | ₩1.55 Billion | -0.96% |
| 2017 | ₩1.57 Billion | +16.39% |
| 2016 | ₩1.35 Billion | -22.62% |
| 2015 | ₩1.74 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Yuhan Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.67 Billion USD |
| MoneyControl | $3.67 Billion USD |
| MarketWatch | $3.67 Billion USD |
| marketcap.company | $3.67 Billion USD |
| Reuters | $3.67 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yuhan Corp.
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more